AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
69.95
-0.81 (-1.14%)
Jun 20, 2025, 4:00 PM - Market closed
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
$583,054
Profits / Employee
$82,418
Market Cap
217.06B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
Eli Lilly and Company | 47,000 |
AZN News
- 8 days ago - 5 Ideal 'Safer' Dividend Buys From Bloomberg's June Watch List - Seeking Alpha
- 9 days ago - AstraZeneca Teams Up With CSPC Pharmaceuticals With Deal Valued at Up to $5.33 Billion - WSJ
- 9 days ago - AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC - Reuters
- 18 days ago - Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO - CNBC
- 20 days ago - 'Transformational' new drug could stop breast cancer tumours before they grow, trial finds - Skynews
- 20 days ago - Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds - Reuters
- 20 days ago - Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial - Business Wire
- 23 days ago - Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine - PRNewsWire